| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.95B | 34.80B | 35.42B | 34.09B | 31.29B | 29.83B |
| Gross Profit | 10.99B | 10.97B | 11.17B | 10.12B | 9.60B | 9.45B |
| EBITDA | 2.90B | 2.89B | 3.07B | 2.38B | 2.08B | 1.91B |
| Net Income | 1.23B | 1.29B | 1.42B | 988.73M | 823.62M | 738.16M |
Balance Sheet | ||||||
| Total Assets | 33.07B | 33.64B | 33.66B | 31.36B | 30.27B | 29.53B |
| Cash, Cash Equivalents and Short-Term Investments | 8.89B | 9.50B | 8.99B | 8.54B | 8.33B | 7.88B |
| Total Debt | 3.34B | 3.84B | 3.83B | 3.61B | 3.60B | 3.81B |
| Total Liabilities | 12.73B | 13.25B | 14.18B | 13.03B | 12.71B | 12.61B |
| Stockholders Equity | 18.27B | 18.30B | 17.50B | 16.48B | 15.83B | 15.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.47B | 1.37B | 639.73M | 948.76M | 623.27M |
| Operating Cash Flow | 0.00 | 2.23B | 2.41B | 1.11B | 1.78B | 1.21B |
| Investing Cash Flow | 0.00 | -993.79M | -1.46B | -443.35M | -684.06M | -568.92M |
| Financing Cash Flow | 0.00 | -730.63M | -492.73M | -454.03M | -630.46M | -509.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥23.06B | 9.20 | ― | 3.89% | 6.99% | -0.30% | |
77 Outperform | ¥12.41B | 10.00 | ― | 3.93% | -1.36% | -18.70% | |
74 Outperform | ¥57.08B | 12.47 | ― | 2.92% | 5.20% | -1.83% | |
69 Neutral | ¥6.30B | 6.12 | ― | 2.22% | 6.80% | -19.87% | |
66 Neutral | ¥31.89B | 11.64 | ― | 0.14% | 9.61% | 53.78% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Toho Acetylene Co., Ltd. has resolved to apply for a change in its market segment from the Prime Market to the Standard Market due to not meeting the required market capitalization criteria for continued listing on the Prime Market. Despite this change, the company remains committed to its growth strategies and aims to enhance corporate governance and investor relations to improve long-term corporate value.
The most recent analyst rating on (JP:4093) stock is a Buy with a Yen395.00 price target. To see the full list of analyst forecasts on Toho Acetylene Co., Ltd. stock, see the JP:4093 Stock Forecast page.
Toho Acetylene Co., Ltd. reported its financial results for the three months ended June 30, 2025, showing a slight increase in net sales by 1.8% compared to the previous year. However, the company experienced a decline in operating profit, ordinary profit, and profit attributable to owners of the parent, indicating challenges in maintaining profitability. Despite these challenges, the company maintains a stable equity ratio and has not revised its financial forecast for the fiscal year ending March 31, 2026, suggesting a cautious but steady outlook.
Toho Acetylene Co., Ltd. has completed the payment for the disposal of 19,000 treasury shares under its restricted stock compensation plan, as resolved in a recent board meeting. This move, involving a total transaction value of 6,669,000 yen, is aimed at compensating the company’s directors and senior vice presidents, potentially impacting its financial management and stakeholder relations.